Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.

Cerebral to pay $7 million fine and limit health data use for ads under federal order

Telehealth company Cerebral will limit the consumer health data it uses for advertising purposes under a new order announced by the Federal Trade Commission Monday.

April 15, 2024

Bourla says Pfizer could transfer production to US to sidestep Trump’s tariffs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 5, 2025

Sernova Corp (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: Sernova Corp – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Sernova Corp Unternehmen: Sernova Corp ISIN: CA81732W1041

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.